Efficacy and safety of early fibrinogen concentrate substitution therapy for severe trauma patients receiving massive transfusions: prospective single arm clinical trial
Phase 2
Recruiting
- Conditions
- severe trauma
- Registration Number
- JPRN-UMIN000010294
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1)history of venous thromboembolism (2)thrombotic diathesis (such as antithrombin deficiency,Protein S/C deficiency,antiphospholipid antibody syndrome) (3)Agreement acquisition is impossible from the patient and the family.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the amount of blood transfusion for 24 hours after the hospital arriving mortality for 72 hours after the hospital arriving morbidity of venous thromboembolism during the hospital stay
- Secondary Outcome Measures
Name Time Method